Koyfin Home > Directory > Health Care > Rigel Pharmaceuticals > Price / Tangible Book Value

Rigel Pharmaceuticals Price / Tangible Book Value Chart (RIGL)

Rigel Pharmaceuticals annual/quarterly Price / Tangible Book Value from 2010 to 2020.
  • Rigel Pharmaceuticals Price / Tangible Book Value for the quarter ending November 11, 2020 was 10.31 a 8.04% increase of 0.83 year over year
  • Rigel Pharmaceuticals Price / Tangible Book Value for the last 12 months ending November 11, 2020 was 10.31 a 8.04% increase of 0.83 year over year
  • Rigel Pharmaceuticals Annual Price / Tangible Book Value for 2020 was 10.31 a 5.79% increase of 0.60 from 2019
  • Rigel Pharmaceuticals Annual Price / Tangible Book Value for 2020 was 9.71 a 0.34% increase of 0.03 from 2019
  • Rigel Pharmaceuticals Annual Price / Tangible Book Value for 2020 was 9.68 a 2.05% increase of 0.20 from 2019
Other Valuation Metrics:
  • Rigel Pharmaceuticals Market Cap for the quarter ending March 03, 2018 was $521m a 35.88% increase of 187m year over year
  • Rigel Pharmaceuticals Price / Book for the quarter ending March 03, 2018 was 5.16 a 23.02% increase of 1.19 year over year
  • Rigel Pharmaceuticals Enterprise Value for the quarter ending March 03, 2018 was $406m a 41.78% increase of 169m year over year
View Chart On Koyfin

Quarterly RIGL Price / Tangible Book Value Data

11/202010.31
11/20209.71
11/20209.68
11/20209.48
11/20209.12
11/20209.02
11/20208.85
11/20209.12
11/20209.08
11/20209.12

Annual RIGL Price / Tangible Book Value Data

202010.31
20209.71
20209.68
20209.48
20209.12
20209.02
20208.85
20209.12
20209.08
20209.12